FDA inspection
Sichuan Renan Pharmaceutical Co., Ltd: FDA inspection ending Mar 21, 2025
FDA inspection 1268221 · No Action Indicated (NAI) · Guangan
Key facts
| Inspection ID | 1268221 |
|---|---|
| Firm | Sichuan Renan Pharmaceutical Co., Ltd |
| FEI number | 3016946731 |
| Address | Renan Section, No. 9 Jinlong Street; Yuechixian |
| City | Guangan |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Mar 21, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data